Ad is loading...
Ad is loading...
DECT vs PNOV
DECT vs PNOV Comparison Chart
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
DECT vs. PNOV commentary
Nov 18, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DECT is a Buy and PNOV is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
PNOV has more net assets: 774M vs. DECT (17M). DECT has a higher annual dividend yield than PNOV: DECT (13.328) vs PNOV (9.379). DECT was incepted earlier than PNOV: DECT (2 years) vs PNOV (5 years).
| DECT | PNOV | DECT / PNOV | |
| Gain YTD | 13.328 | 9.379 | 142% |
| Net Assets | 17M | 774M | 2% |
| Total Expense Ratio | N/A | N/A | - |
| Turnover | N/A | 0.00 | - |
| Yield | 0.46 | 0.00 | - |
| Fund Existence | 2 years | 5 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| DECT | PNOV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 35% | 3 days ago 31% |
| Stochastic ODDS (%) | 3 days ago 42% | 3 days ago 37% |
| Momentum ODDS (%) | 3 days ago 82% | N/A |
| MACD ODDS (%) | 3 days ago 76% | 3 days ago 57% |
| TrendWeek ODDS (%) | 3 days ago 80% | 3 days ago 56% |
| TrendMonth ODDS (%) | 3 days ago 79% | 3 days ago 54% |
| Advances ODDS (%) | 3 days ago 74% | 10 days ago 56% |
| Declines ODDS (%) | N/A | 3 days ago 56% |
| BollingerBands ODDS (%) | 3 days ago 33% | 3 days ago 29% |
| Aroon ODDS (%) | 3 days ago 81% | 3 days ago 52% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TARZX | 25.22 | -0.04 | -0.16% |
| Third Avenue Real Estate Value Z | |||
| FDMLX | 11.46 | -0.09 | -0.78% |
| Fidelity Series Intrinsic Opps | |||
| FDCPX | 110.18 | -1.09 | -0.98% |
| Fidelity Select Tech Hardware | |||
| PEDGX | 13.59 | -0.16 | -1.16% |
| Principal Edge MidCap Institutional | |||
| PAMCX | 103.77 | -2.05 | -1.94% |
| T. Rowe Price Mid-Cap Growth Adv | |||